Revolutionizing Microsurgery: MMI Announces First U.S. Cases Using Symani® Surgical System
The Symani® Surgical System, a groundbreaking robotic technology designed to revolutionize microsurgery, has made its debut in the United States with the completion of its first clinical cases. Developed by MMI (Medical Microinstruments, Inc.), this innovative system is set to usher in a new era in soft tissue open surgery.
The inaugural procedures took place at Penn Medicine, Penn Presbyterian Medical Center, where two robotic-assisted microsurgical operations were successfully performed. The first case involved a “free bone transfer” procedure on a patient with a traumatic injury, while the second case focused on repairing a severe knee wound to prevent amputation.
Mark Toland, CEO of MMI, expressed his excitement about this milestone, stating that the Symani Surgical System will provide expanded treatment options for patients requiring complex microsurgical techniques. With the recent FDA approval, this system is now the only commercially available platform in the U.S. for reconstructive microsurgery.
By enabling surgeons to replicate the intricate movements of the human hand at a micro scale, the Symani Surgical System can address the challenges of anastomosis and suturing of small anatomical structures during open surgical procedures. This advancement is expected to enhance patient outcomes, increase the number of surgeons capable of performing complex procedures, and allow hospitals to expand their open surgical programs.
To learn more about MMI and the Symani Surgical System, visit MMI’s website at https://mmimicro.com. This groundbreaking technology is poised to transform the field of microsurgery and improve the lives of patients with complex conditions.
For more information, you can view the source version on businesswire.com: https://www.businesswire.com/news/home/20240501137865/en/
Media Contact:
Dan Ventresca
Matter Health for MMI
MMI@matternow.com
Investor Relations Contact:
Lisa Croke
Lisa.Croke@mmimicro.com